Literature DB >> 1102398

Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy.

B G Gazzard, J M Henderson, R Williams.   

Abstract

Early changes in coagulation were found in patients following a paracetamol overdose. Low levels of clotting factors II, V and VII were present within 24 hours of the overdose. As the levels of factor II correlated with plasma fibrinogen values at this time, it is possible that they were consumed in the process of intravascular coagulation, although this was not supported by the presence of raised titres of fibrin degradation products. The prothrombin time ratio was greater than 2-2 within 30 hours of ingestion of the overdose in all patients who eventually died, whereas it was less than this in those developing only moderate liver damage. The administration of fresh frozen plasma to patients did appear to reduce the maximum abnormality of the prothrombin time ratio, which was significantly less three days after the overdose in the group receiving fresh frozen plasma. However, the coagulation disturbance was of short duration, and the prothrombin time ratio had also returned to normal within one week of the overdose in the control patients, and the administration of fresh frozen plasma did not appear to reduce the morbidity or mortality in the treated patients.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1102398      PMCID: PMC1411015          DOI: 10.1136/gut.16.8.617

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  11 in total

1.  Protection of rats against the hepatotoxic effect of paracetamol.

Authors:  B G Gazzard; R D Hughes; B Portmann; B Dordoni; R Williams
Journal:  Br J Exp Pathol       Date:  1974-12

2.  Hepatic damage and death from overdose of paracetamol.

Authors:  R Clark; V Borirakchanyavat; A R Davidson; R P Thompson; B Widdop; R Goulding; R Williams
Journal:  Lancet       Date:  1973-01-13       Impact factor: 79.321

3.  Plasma-paracetamol half-life and hepatic necrosis in patients with paracetamol overdosage.

Authors:  L F Prescott; P Roscoe; N Wright; S S Brown
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

4.  Experimental hepatic necrosis: studies on coagulation abnormalities, plasma clearance, and organ distribution of 125I-labelled fibrinogen.

Authors:  M O Rake; P T Flute; G Pannell; K B Shilkin; R Williams
Journal:  Gut       Date:  1973-07       Impact factor: 23.059

5.  Disorderd hemostasis in liver damage from paracetamol overdose.

Authors:  R Clark; V Borirakchanyavat; B G Gazzard; M O Rake; K B Shilkin; P T Flute; R Williams
Journal:  Gastroenterology       Date:  1973-11       Impact factor: 22.682

6.  Evaluation of corticosteroid and exchange-transfusion treatment of acute yellow-phosphorus intoxication.

Authors:  G A Marin; C A Montoya; J L Sierra; J R Senior
Journal:  N Engl J Med       Date:  1971-01-21       Impact factor: 91.245

7.  A rapid, simple, sensitive method for measuring fibrinolytic split products in human serum.

Authors:  C Merskey; P Lalezari; A J Johnson
Journal:  Proc Soc Exp Biol Med       Date:  1969-07

8.  A controlled trial of heparin therapy in the coagulation defect of paracetamol-induced hepatic necrosis.

Authors:  B G Gazzard; R Clark; V Borirakchanyavat; R Williams
Journal:  Gut       Date:  1974-02       Impact factor: 23.059

9.  Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.

Authors:  B G Gazzard; M L Lewis; G Ash; C R Rizza; E Bidwell; R Williams
Journal:  Gut       Date:  1974-12       Impact factor: 23.059

10.  Early and intensive therapy of intravascular coagulation in acute liver failure.

Authors:  M O Rake; P T Flute; K B Shilkin; M L Lewis; J Winch; R Williams
Journal:  Lancet       Date:  1971-12-04       Impact factor: 79.321

View more
  16 in total

1.  4 Plasma for Therapeutic Use.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 2.  Acute liver failure and liver transplantation.

Authors:  Nobuhisa Akamatsu; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2013-08

Review 3.  Acute hepatic failure: limitations of medical treatment and indications for liver transplantation.

Authors:  M Peters; K H Meyer zum Büschenfelde; G Gerken
Journal:  Clin Investig       Date:  1993-11

Review 4.  Paracetamol overdosage. Pharmacological considerations and clinical management.

Authors:  L F Prescott
Journal:  Drugs       Date:  1983-03       Impact factor: 9.546

Review 5.  Paracetamol.

Authors:  T J Meredith; R Goulding
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

6.  Fibrin(ogen)-independent role of plasminogen activators in acetaminophen-induced liver injury.

Authors:  Bradley P Sullivan; Karen M Kassel; Alice Jone; Matthew J Flick; James P Luyendyk
Journal:  Am J Pathol       Date:  2012-04-13       Impact factor: 4.307

Review 7.  Non-narcotic analgesics. Problems of overdosage.

Authors:  T J Meredith; J A Vale
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 8.  Role of hemostatic factors in hepatic injury and disease: animal models de-liver.

Authors:  A K Kopec; N Joshi; J P Luyendyk
Journal:  J Thromb Haemost       Date:  2016-05-10       Impact factor: 5.824

Review 9.  Intensive liver care and management of acute hepatic failure.

Authors:  R Williams; A E Gimson
Journal:  Dig Dis Sci       Date:  1991-06       Impact factor: 3.199

10.  The coagulopathy of acute liver failure and implications for intracranial pressure monitoring.

Authors:  Santiago J Munoz; K Rajender Reddy; William Lee
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.